STAT Plus: What the Democrats stated about ‘large pharma’ — and why it issues

WASHINGTON — Virtually the primary phrases spoken on the first Democratic major debate on Wednesday zeroed in on drug firms, as Sen. Elizabeth Warren (Mass.) fingered biopharma as a chief instance of company extra and a wrongdoer for an financial system skewed in favor of the rich.

Democrats rushed to echo Warren’s remarks, sharply criticizing “Huge Pharma” for its lobbying presence in Washington, for prime drug costs, and for furthering the opioid disaster. All instructed, 9 of the 20 candidates labored drug trade jabs into their remarks.

Unlock this text by subscribing to STAT Plus and luxuriate in your first 30 days free!


What’s it?

STAT Plus is a premium subscription that delivers every day market-moving biopharma protection and in-depth science reporting from a crew with a long time of trade expertise.

What’s included?

Authoritative biopharma protection and evaluation, interviews with trade pioneers, coverage evaluation, and first seems at innovative laboratories and early stage analysis
Subscriber-only networking occasions and panel discussions throughout the nation
Month-to-month subscriber-only stay chats with our reporters and consultants within the area
Discounted tickets to trade occasions and early-bird entry to trade reviews